StemCyte to conduct clinical trials for spinal cord injuries in India
After conducting clinical trials for spinal cord injuries in the US and China, US-based stemcell transplantation and therapeutics company, StemCyte Inc is planning to conduct the same in India next year.
The company has set up a first-of-its-kind umbilical cord blood (UCB) public bank for India in a joint venture with Chennai-based Apollo Hospitals and Ahmedabad-based Cadila Pharmaceuticals. All set to be operational by the end of this year on the hospital premises in Ahmedabad, the new entity, called StemCyte India Therapeutics Pvt Ltd (SCITPL), will aid in carrying out clinical trials in India. Continue Reading »







CAPE MAY – The city’s beach patrol and fire rescue personnel have answered 20 C-Spine (neck, cervical and spine) injury calls since June 26.